Latest / Pharmacy Podcast Network / NASP 2024 Annual Meeting LIVE ReCap Show Part Two | NASP Specialty Pharmacy Podcast
Transcript
- 0:05Speaker 1: You are listening to the global network of podcasters dedicated
- 0:08Speaker 1: to the pharmacy profession. Welcome to the Pharmacy Podcast Network.
- 0:24Speaker 2: Welcome back to the Pharmacy podcast Networks coverage of the
- 0:27Speaker 2: NASP twenty twenty four. We're thrilled to be back interviewing
- 0:31Speaker 2: specialty pharmacy leaders with our special four part series covering
- 0:34Speaker 2: the annual meeting and expo held in Nashville from October
- 0:37Speaker 2: sixth through the ninth. As the official press and media
- 0:40Speaker 2: partner for NASP, we're here to bring you the latest
- 0:43Speaker 2: insights and highlights from this important gathering. This year, industry
- 0:47Speaker 2: thought leaders and healthcare veterans from across the nation united
- 0:50Speaker 2: to discuss the future of specialty pharmacy in the evolving
- 0:52Speaker 2: patient journey. And now here's our host, Todd Yuriy, CEO
- 0:57Speaker 2: and founder of the Pharmacy Podcast Network, interview viewing with
- 1:00Speaker 2: our sponsor Accessia.
- 1:02Speaker 3: Health Eccessia Health here with me at the NASP twenty
- 1:06Speaker 3: twenty four, which has been our press sponsor. And I
- 1:10Speaker 3: think this is a second time that you've helped us
- 1:13Speaker 3: be here at the NASP, or it might have been
- 1:16Speaker 3: a Sembia. I'm starting to get all these conferences mixed up.
- 1:18Speaker 3: I'm here with Jennifer Noonan. Welcome to the show, Jennifer, Thanks,
- 1:22Speaker 3: good to be here.
- 1:23Speaker 4: Todd, Well, I think it was a SMIA. It was
- 1:26Speaker 4: pretty sure it was.
- 1:27Speaker 5: Yeah. We just this year has gone by so fast.
- 1:32Speaker 3: ACCESSIA has helped us to understand how important in the
- 1:35Speaker 3: ecosystem of specialty pharmacy, specifically, payment disrupts the flow of
- 1:41Speaker 3: treatment and if you don't have someone on your side
- 1:44Speaker 3: for the patient to really understand where they can go
- 1:47Speaker 3: if funding isn't available, that is part of the therapy.
- 1:51Speaker 5: It's it's the bigger picture.
- 1:52Speaker 3: So just in starting out, I want to hear a
- 1:54Speaker 3: little bit of your background. I certainly know you, but
- 1:56Speaker 3: our listeners might not. Just give us a little bit
- 1:59Speaker 3: about you and what you do at Excessia Health.
- 2:03Speaker 4: Yeah, so I think you and I go back and remembran.
- 2:06Speaker 4: It's about my background because your mother was a nurse.
- 2:10Speaker 5: Yep, is that correct? And my wife's a nurse.
- 2:12Speaker 4: Too, Okay, So I'm a nurse by trade and training.
- 2:16Speaker 4: Worked in the que care for about seventeen years in
- 2:20Speaker 4: the hospital setting emergency and trauma, and moved from there
- 2:26Speaker 4: in twenty thirteen to the hospice world, and at some
- 2:30Speaker 4: point ended up with overseeing the pediatric hospice population, which
- 2:37Speaker 4: was a great deal different than any of the other
- 2:40Speaker 4: types of care that I'd given. But kind of the
- 2:44Speaker 4: little joke that I make, if if you will, about
- 2:47Speaker 4: pharmacy and specialty pharmacy was that when I worked in
- 2:49Speaker 4: the er and was down in the trenches, we thought
- 2:52Speaker 4: all pharmacy was special because they were coming to the
- 2:56Speaker 4: bedside and mixing those meds with us in acute situation.
- 3:00Speaker 4: But there really wasn't a distinction between the pharmacy that
- 3:04Speaker 4: was available in the hospital setting or even out in
- 3:09Speaker 4: the community to seeing this change into more complex medications
- 3:15Speaker 4: that required a pharmacy to kind of cater to that population.
- 3:21Speaker 4: I discovered that when I moved into hospice care as
- 3:24Speaker 4: we had some patients who were suffering with complex health problems.
- 3:28Speaker 3: You're also a member of the NASP's board of Directors,
- 3:32Speaker 3: and it's interesting that you're part of that in shaping
- 3:36Speaker 3: what they are doing in support of specially pharmacy from
- 3:39Speaker 3: a nurse perspective that is actually hands on and caring
- 3:42Speaker 3: for patients from a payment perspective, because like I said,
- 3:45Speaker 3: that's a huge part of our ecosystem. How do your
- 3:50Speaker 3: roles at NASP and Excess ther Health, how do they
- 3:53Speaker 3: complement each other?
- 3:55Speaker 4: Yeah, it is a bit of an interesting matchup, and
- 3:58Speaker 4: I think is a good question that I've heard a
- 4:01Speaker 4: lot since we've become so involved with NASP. But as
- 4:06Speaker 4: I moved into a different industry, if you will, having
- 4:10Speaker 4: come from direct patient care and working within the pay
- 4:14Speaker 4: systems that were pretty clearly guided by Joint Commission and
- 4:20Speaker 4: CMS rules, I moved into a different arena and we
- 4:25Speaker 4: had a lot of patients that were getting medication through
- 4:29Speaker 4: specialty pharmacies that we were helping bridge that gap. But
- 4:34Speaker 4: my understanding of all of the inner workings of specialty
- 4:38Speaker 4: pharmacy and the different support services they did have to
- 4:42Speaker 4: offer to different patients and different areas of health problems,
- 4:48Speaker 4: it was a way for me to immerse myself into
- 4:52Speaker 4: the environment and learn. So I joined some committees that
- 4:57Speaker 4: had the patient in the center of the focus for education,
- 5:02Speaker 4: and from there just you know, made a lot of
- 5:05Speaker 4: great connections with different specialty pharmacy individuals, folks even in
- 5:12Speaker 4: the research side of things, to help me better understand
- 5:15Speaker 4: the diseases themselves, and so for excessi health. It's been
- 5:20Speaker 4: a really great way to bridge a knowledge gap between
- 5:24Speaker 4: the actual patient experience from the financial neediness standpoint, which
- 5:29Speaker 4: is pretty much anyone who has a rare disease in
- 5:32Speaker 4: this day and age is going to cause some financial hardship,
- 5:37Speaker 4: all right.
- 5:37Speaker 3: So accessing your health is that funding source someone that
- 5:40Speaker 3: comes alongside partners with the patient patient's family caregivers. How
- 5:45Speaker 3: do you specifically work with specialty pharmacies to improve patient outcomes?
- 5:51Speaker 4: Well, we are working with developing relationships with any and
- 5:55Speaker 4: all specialty pharmacies that serve patients that are in the
- 5:58Speaker 4: same population that we are also supporting. We want to
- 6:02Speaker 4: ensure that there's a very clear understanding of ways in
- 6:07Speaker 4: which we can be of assistance to individuals that are
- 6:11Speaker 4: having a financial hardship with getting their treatments met. But
- 6:16Speaker 4: in addition to that, we want to understand any problems
- 6:19Speaker 4: or barriers that they've had to helping people get on
- 6:24Speaker 4: our service or go through that enrollment process. So really
- 6:27Speaker 4: just a way to collaborate and bring the patient experience
- 6:32Speaker 4: to the highest level we can.
- 6:34Speaker 5: When we return, we're going to take a quick break.
- 6:37Speaker 3: We're going to talk with Jennifer about a special webinar
- 6:41Speaker 3: that you just had that came through and I want
- 6:44Speaker 3: to dig into that because I think it's important for
- 6:46Speaker 3: our listeners to really understand how access he is leading
- 6:50Speaker 3: in funding and some of the changes in CMS and
- 6:54Speaker 3: things that you've done to map that out. So stay
- 6:57Speaker 3: tuned to the NASP podcast. Will be right back.
- 7:07Speaker 6: Need Excessia Health.
- 7:09Speaker 2: A charitable patient assistance organization that's helping people with rare
- 7:13Speaker 2: or chronic conditions afford their medications and other healthcare costs.
- 7:18Speaker 3: Accessia Health is a national, nonprofit patient assistance organization that
- 7:22Speaker 3: supports individuals with rare or chronic conditions. They provide financial
- 7:27Speaker 3: assistance for healthcare costs including medication copas, insurance premiums, travel,
- 7:33Speaker 3: and other essential medical expenses. Plus they offer healthcare education,
- 7:38Speaker 3: a free legal aid program, and case management services.
- 7:42Speaker 2: Join Excessia Health at NASP twenty twenty four in Nashville
- 7:46Speaker 2: Visit Booth one twenty seven to learn how you can
- 7:48Speaker 2: make a meaningful impact on the lives of individuals living
- 7:51Speaker 2: with rare diseases or chronic conditions. Discover more at excessiahealth
- 7:56Speaker 2: dot org.
- 7:58Speaker 3: All right, we're back here Ana SP Podcast with Jennifer
- 8:02Speaker 3: Noonan with Excessia Health. So you hosted a webinar series
- 8:06Speaker 3: about the Inflation Reduction Act in Medicare changes.
- 8:09Speaker 5: I want you to share with.
- 8:11Speaker 3: What you did with that webinar and how that's going
- 8:15Speaker 3: to impact specialty pharmacy.
- 8:18Speaker 4: Yeah, so this was a webinar series event that just
- 8:21Speaker 4: surrounded the IRA and the impact that we felt, like
- 8:26Speaker 4: all individuals who are on medications of any kind, which
- 8:30Speaker 4: is pretty much millions of people in the US, but
- 8:33Speaker 4: many of those individuals are also receiving assistance through different
- 8:39Speaker 4: charitable organizations such as Excessia Health, and so in our
- 8:45Speaker 4: journey to fully understand all of the different implications that
- 8:49Speaker 4: might come with that and all of the different stakeholders
- 8:52Speaker 4: involved and what are the steps in processing those claims
- 8:55Speaker 4: so that we can be proactive in ensuring that we
- 8:59Speaker 4: have as little disruption as possible, if at all. And
- 9:03Speaker 4: so the first series part was with CMS. We had
- 9:08Speaker 4: Christy Martin, who is chief of staff, came on for
- 9:12Speaker 4: an hour long webinar talking about all of the different
- 9:16Speaker 4: implications that we might expect to see with the rollout
- 9:20Speaker 4: of these changes in the next two years. And the
- 9:24Speaker 4: follow up to that webinar was with will William Serell.
- 9:30Speaker 4: He is a renowned legal expert in healthcare and speaks
- 9:35Speaker 4: often on rare disease and access to medications, so it's
- 9:39Speaker 4: very insightful.
- 9:40Speaker 5: We already got back some survey.
- 9:42Speaker 4: Results from the first webinar series about CMS and some
- 9:47Speaker 4: of the implications, and it was surprising to see that
- 9:49Speaker 4: over sixty five percent of the folks that responded stated
- 9:53Speaker 4: that they had little to know knowledge about those various
- 9:58Speaker 4: topics that she brought up during the w and on.
- 10:01Speaker 3: That's interesting because how can we expect our patients to
- 10:04Speaker 3: understand how to navigate payment and benefits if our providers
- 10:08Speaker 3: and our lead people that are touching them in the
- 10:12Speaker 3: specially pharmacy realm that they don't understand it. So Excessia
- 10:16Speaker 3: bringing this knowledge to us in specially pharmacy specifically, that's
- 10:20Speaker 3: really special. So talk to us about where you see
- 10:25Speaker 3: the future going and how Accessia is aligning with specialty
- 10:29Speaker 3: pharmacy to make sure things that are getting paid for.
- 10:32Speaker 3: What are some of the other next steps that Excessia
- 10:35Speaker 3: is going to do to educate our markets.
- 10:37Speaker 4: Well, we're still working with CMS to outline all of
- 10:41Speaker 4: the detailed specifics on how those various payments are going
- 10:46Speaker 4: to be routed once they get the patient's treatment on board.
- 10:52Speaker 4: What I've seen so far in this arena has been
- 10:56Speaker 4: the talk being very heavy about the IRA, how that's
- 11:00Speaker 4: going to impact individuals who are seeking help for paying
- 11:05Speaker 4: for their medications, and then in addition to that, how
- 11:07Speaker 4: that's going to look with gene and cell therapy coming
- 11:11Speaker 4: down the road. So we're trying to plan ahead and
- 11:13Speaker 4: be ready for whatever it is that's coming so we
- 11:16Speaker 4: can help people in the best way possible.
- 11:18Speaker 3: For our listeners, I want you to know that accessia
- 11:21Speaker 3: Health has a YouTube channel. You can also go to
- 11:25Speaker 3: their website at eccesshealth dot org and click on the
- 11:28Speaker 3: educational resources at the top of their website to find
- 11:32Speaker 3: the webinar's page. You can also google eccessia health and
- 11:37Speaker 3: put in even into video the word video in there.
- 11:41Speaker 3: We're going to be sharing links throughout the Pharmacy podcast
- 11:44Speaker 3: network about Excessihealth. Follow them on Instagram as well as LinkedIn.
- 11:51Speaker 5: Jennifer.
- 11:52Speaker 3: This continuing education where we're constantly coming back and in
- 11:56Speaker 3: this case through podcasting. People are going to work right now,
- 11:59Speaker 3: they're jogging, the talking, they're listening. If they don't understand
- 12:02Speaker 3: that excessia is available to them and their patients, you're
- 12:06Speaker 3: not going to use it. So I'm going to give
- 12:08Speaker 3: a shout out to our specialty pharmacies to reach out
- 12:12Speaker 3: to Jennifer. You're active on LinkedIn, so I want them
- 12:15Speaker 3: to actually put in your name Noonan N N A
- 12:20Speaker 3: N that's right, all right, Sorry, so Jennifer Noonan with
- 12:24Speaker 3: Excessia Health. This has been fun to work with you.
- 12:28Speaker 3: It means a lot to us that you are supporting us.
- 12:31Speaker 3: It means even more to us that you're supporting people
- 12:33Speaker 3: that are desperately needing funding for specialty meds, which can
- 12:37Speaker 3: rock anybody's budget. And what's happening, you know, year after year,
- 12:43Speaker 3: month after month, and dealing with some kind of chronic disease.
- 12:46Speaker 3: Before we wrap up, is there anything that you wanted
- 12:48Speaker 3: to share with our listeners and how they can get
- 12:51Speaker 3: more involved with Excessia Health.
- 12:54Speaker 4: Well, again, you've already given out the link to our
- 12:57Speaker 4: web page. But if you are jogging or getting out
- 13:00Speaker 4: of your car right now and you didn't catch that,
- 13:01Speaker 4: if you navigate to accessia A C C E S
- 13:05Speaker 4: s I ahealth dot org, we have a page that
- 13:09Speaker 4: says how how can I join in? And so we
- 13:13Speaker 4: do have some opportunities coming up. We're expanding our Patient
- 13:18Speaker 4: Advisory Committee, so there's going to be more information coming
- 13:21Speaker 4: out about that, but there's a link to apply, and
- 13:25Speaker 4: so we also have an area for folks who want
- 13:30Speaker 4: to get involved or help out and make donations. There
- 13:34Speaker 4: is a place on the page.
- 13:35Speaker 5: For that as well.
- 13:37Speaker 3: Excellent, Jennifer, thank you so much for being here at
- 13:39Speaker 3: the NAESP and being part of our wrap up show on.
- 13:43Speaker 5: The NESP podcast.
- 13:48Speaker 3: And we're back at the NASP and Jonathan Argachak is here.
- 13:53Speaker 5: It's so good to see you.
- 13:54Speaker 7: Likewise, thanks for having me back again.
- 13:56Speaker 3: Every time we meet up with you, you've developed something or
- 14:00Speaker 3: come out with something or have leveled up and it's
- 14:03Speaker 3: just what it's so cool to watch your career and
- 14:06Speaker 3: what you've done in workflow with STACK. Also your involvement
- 14:10Speaker 3: in the Certified Specially Pharmacy. Talk to us about zeal,
- 14:17Speaker 3: your new Specially Pharmacy and what you guys are doing.
- 14:19Speaker 8: Yes, it has been taking off like wildfire, and you good,
- 14:25Speaker 8: good and bad that comes with that. Yeah, but you
- 14:27Speaker 8: know it's been something that we've been able to do
- 14:28Speaker 8: that's very manageable and something that I think we're at
- 14:32Speaker 8: a point right now where when you build a business plan,
- 14:34Speaker 8: you put it together. I think we're at year four
- 14:37Speaker 8: of where we thought we would be and we're only
- 14:39Speaker 8: into nine months of dispensing. So I mean like it's
- 14:42Speaker 8: showing that the model that we built really works and
- 14:45Speaker 8: it's allowing us to build really good patient experiences using
- 14:49Speaker 8: some technology and kind of scale that much more effectively
- 14:53Speaker 8: because we can build the workflows and build the efficiencies
- 14:56Speaker 8: in that you don't get to see everywhere.
- 14:58Speaker 3: Else one that people might not realize listening, but Jonathan
- 15:04Speaker 3: almost has created a lab in of what is Zeal
- 15:08Speaker 3: to test all of his technology on. Through what Stack
- 15:11Speaker 3: has done, you've had an advantage over startup specially pharmacies
- 15:16Speaker 3: because you actually help to start up a specially pharmacy
- 15:21Speaker 3: back in the day that then you help to develop
- 15:23Speaker 3: Stack and then now it's come full circle because you're
- 15:26Speaker 3: putting these techts and these processes and these workflows in
- 15:29Speaker 3: your own specialty pharmacy and you're quickly assessing what works
- 15:33Speaker 3: and what doesn't. Talk to me about like white paper
- 15:36Speaker 3: development or something that can come out of this to
- 15:38Speaker 3: help other specialty forms.
- 15:39Speaker 8: Well, you know the one thing that it's kind of
- 15:41Speaker 8: funny you mentioned that we have. I mean they're separate companies,
- 15:43Speaker 8: the software versus the pharmacy. But somebody liking it to
- 15:46Speaker 8: an Ikea the other day and I was like, what
- 15:48Speaker 8: do you mean it's like an Ikea, And I said, well,
- 15:49Speaker 8: would you go to Ikea. You're going to look and
- 15:51Speaker 8: see what that dresser looks like in a room decide
- 15:54Speaker 8: if you able to buy it. And they said, you've
- 15:56Speaker 8: done that, but it's for a pharmacy. You get to
- 15:57Speaker 8: see how the software works, you get to see how
- 15:59Speaker 8: it functions, and you can make those changes before it
- 16:02Speaker 8: ever makes it out into the wild.
- 16:05Speaker 9: And it's been a really cool experience to be able
- 16:07Speaker 9: to build that.
- 16:08Speaker 7: But part of what we do is we are able
- 16:11Speaker 7: to look at.
- 16:11Speaker 8: Some of these disease states that there needs to be better,
- 16:14Speaker 8: more meaningful real world data or outcomes data, and we
- 16:18Speaker 8: can ourselves or because the software could be used across
- 16:22Speaker 8: multiple pharmacies, we can aggregate that data and do it
- 16:25Speaker 8: in a way that we could de identify it. We
- 16:27Speaker 8: could share it with schools of pharmacy, because you know,
- 16:30Speaker 8: there's got to be some doctoral candidate out there that's
- 16:33Speaker 8: looking to have data to assess, to rate their dissertation,
- 16:35Speaker 8: why wouldn't we give them some real, real world data
- 16:39Speaker 8: to give them to evaluate an assess. So it allows
- 16:41Speaker 8: us to be able to do those sorts of things.
- 16:44Speaker 8: It also allows us to prove that the model works.
- 16:46Speaker 8: We're finishing up our white paper right now. At zeal
- 16:49Speaker 8: we were able to get all fifty state licensure plus
- 16:52Speaker 8: EUREK and ACHC accredited plus rare disease designations from both
- 16:57Speaker 8: of those entities in eight months, and I still I'd
- 17:02Speaker 8: like to go on records, and I think that's the
- 17:03Speaker 8: fastest that anybody's ever done it.
- 17:05Speaker 7: But we're writing the white paper to prove that day.
- 17:07Speaker 8: Most cases, especially when I was doing that consulting or
- 17:09Speaker 8: doing it myself in past lives, it took a lot
- 17:12Speaker 8: longer yo eighteen to twenty four months, and so it's
- 17:15Speaker 8: kind of putting our money where our mouth is to
- 17:17Speaker 8: show that this We know that this works, we can
- 17:19Speaker 8: prove that it works, and here's evidence that that actually happened.
- 17:23Speaker 7: So we'll have a white paper coming up very soon.
- 17:24Speaker 5: That's exciting.
- 17:25Speaker 3: I want to podcast that white paper, so let's talk
- 17:29Speaker 3: about manufacturers recognizing efficiency and excellence in this, and I
- 17:35Speaker 3: think that's where the white paper might give you more exposure.
- 17:38Speaker 3: But if a manufacturer realized what you've done in order
- 17:42Speaker 3: to get to this point, and how fast you got
- 17:44Speaker 3: here and how high quality that you got here, that
- 17:48Speaker 3: you weren't skipping steps and you were doing everything you're
- 17:50Speaker 3: supposed to, I think that paints an interesting picture for
- 17:53Speaker 3: the future of startup specialty pharmacies. To follow a model
- 17:57Speaker 3: that you've helped to create, with tools that you helped
- 17:59Speaker 3: to create, you're kind of like the George Lucas of
- 18:02Speaker 3: science fiction, because when he was making his movies in
- 18:06Speaker 3: the seventies, there was no technology to do the special effects.
- 18:10Speaker 3: He built the tools, and he built LMC or LMI
- 18:14Speaker 3: or whatever his division was in order to get his
- 18:18Speaker 3: special effects that came as part of the movie.
- 18:20Speaker 9: That's actually what you did.
- 18:21Speaker 7: I've never heard that comparison before.
- 18:23Speaker 8: I feel like I'm going to use it some conversation
- 18:26Speaker 8: with somebody, But yeah, I mean, you walk around an
- 18:29Speaker 8: exhibit hall like this and there's a lot of great solutions,
- 18:31Speaker 8: but unless you've been in the trenches working at a pharmacy,
- 18:35Speaker 8: it may make it a little bit more difficult to
- 18:37Speaker 8: implement some of those things, and so we've always said,
- 18:39Speaker 8: what can we do to build solutions or partner with
- 18:42Speaker 8: companies that have solutions, and we're just bringing all of
- 18:45Speaker 8: that together. We're making it easier because there's enough to
- 18:48Speaker 8: go around in its industry and there's enough patients that
- 18:51Speaker 8: need to be helped. Absolutely, if we can find ways
- 18:53Speaker 8: to do it in a more scalable fashion, then everybody wins,
- 18:57Speaker 8: and most importantly, the patient does at the end of
- 18:59Speaker 8: the day.
- 19:00Speaker 3: Jonathan, thank you for being part of the show again.
- 19:02Speaker 3: I always like touching base with you and seeing where
- 19:05Speaker 3: you are. You're a fellow Pittsburgh. I want to see
- 19:07Speaker 3: you win. We can't wait to come down and seeze.
- 19:10Speaker 3: I keep saying I'm going to do it, but we
- 19:11Speaker 3: have to get it on the books.
- 19:12Speaker 8: I'd love for you to come in livestream at the Formacy,
- 19:15Speaker 8: but we'll get you set up so that way there's
- 19:17Speaker 8: a home for you there and you know, we could
- 19:19Speaker 8: kind of kind of run some shows there if you'd
- 19:20Speaker 8: be interested.
- 19:21Speaker 3: So happy to have you down, doctor Jonathan Orgchek, thank
- 19:23Speaker 3: you for being part of the NSP podcast.
- 19:25Speaker 7: Thanks for having me back.
- 19:30Speaker 5: You are listening to the.
- 19:31Speaker 3: NASP podcast, part of the Pharmacy Podcast Network. Julian de
- 19:37Speaker 3: Francis here from Blue Sky Specialty Pharmacy.
- 19:40Speaker 5: Welcome to the NSP podcast.
- 19:42Speaker 10: Thank you.
- 19:42Speaker 5: I'm a pleasure to be here.
- 19:44Speaker 6: I'm excited.
- 19:45Speaker 3: You said to me that you are not new to NEASP.
- 19:49Speaker 3: We used to say NASP and now we see NASP.
- 19:51Speaker 3: But talk to us about your involvement with the association.
- 19:55Speaker 3: How long you've been coming and what this means to
- 19:57Speaker 3: you as a specialty pharmacy profession Well.
- 20:00Speaker 11: Thank you.
- 20:01Speaker 10: Yes, being with the Independent Specialty Pharmacy, I've been coming
- 20:05Speaker 10: to NSP for about oh gosh, I think this is
- 20:10Speaker 10: my fifth or sixth NAESP and I've seen it evolution happen,
- 20:14Speaker 10: and I've seen it grow, which is exciting to me
- 20:16Speaker 10: because I feel ANESP has a wonderful message they're trying
- 20:19Speaker 10: to get out there about the wonderful work that specialty
- 20:22Speaker 10: pharmacies do. So I'm very passionate about that as well.
- 20:27Speaker 10: Joined the Customer Experience Committee about five years ago and
- 20:32Speaker 10: now I chair it and so we produce the Patient
- 20:36Speaker 10: Satisfaction Survey year.
- 20:38Speaker 3: Well that's incredible. You know that patient Satisfy UH Satisfaction
- 20:42Speaker 3: survey just came out. Glad that you're referencing it. It
- 20:45Speaker 3: was a very powerful document for specialty pharmacists to really
- 20:49Speaker 3: understand what's going on share with us. Some of the
- 20:51Speaker 3: metrics are some of the things that were glaring that
- 20:53Speaker 3: stood out to you from that that survey.
- 20:56Speaker 10: Right, so we started, we noticed that there was a need. Basically,
- 21:01Speaker 10: historically specialty pharmacies weren't using some of their own homegrown
- 21:05Speaker 10: surveys or a different survey from a different industry. So
- 21:10Speaker 10: an ESP being the thought leader, hired Soul of a
- 21:14Speaker 10: Lulin group to actually administer the surveys. So yearly we
- 21:18Speaker 10: take a look at all the participating pharmacies that are
- 21:22Speaker 10: utilizing the survey tool and do Solivan Lulan does all
- 21:26Speaker 10: the data stratification of the data and then we do
- 21:30Speaker 10: present it in a white paper. But this year and
- 21:33Speaker 10: last year, which we have found very interesting is the
- 21:36Speaker 10: two key drivers for patients satisfaction.
- 21:39Speaker 5: Has stayed the same.
- 21:40Speaker 10: So that tells us that the patients really have a
- 21:42Speaker 10: voice and what they really want to see and expect
- 21:46Speaker 10: from their specialty pharmacy. So to those two drivers is
- 21:49Speaker 10: basically the overall communication that they have with the pharmacy
- 21:53Speaker 10: and also their confidence and trust and the pharmacist and nurse.
- 21:57Speaker 6: Very good.
- 21:57Speaker 3: Yeah, right, What else stood out in the data that
- 21:59Speaker 3: came out? What kind of feedback are you getting from
- 22:02Speaker 3: specialty pharmacies that have read the paper about how they're
- 22:05Speaker 3: going to pivot in order to really concentrate more on
- 22:07Speaker 3: the patients satisfaction.
- 22:09Speaker 10: Right, great question, and we're seeing that there's an uptick
- 22:13Speaker 10: and utilizing this survey tool. There are other survey tools
- 22:18Speaker 10: out there now, but the benefit to ours is there's
- 22:22Speaker 10: actual items, so reading the paper, seeing how patients have responded,
- 22:27Speaker 10: actually participating in the survey itself. We have a like
- 22:32Speaker 10: a basically a portal tool, and you can go in
- 22:35Speaker 10: there and if you're participating in the survey, download in
- 22:39Speaker 10: actionable items and so that will give you keys into
- 22:43Speaker 10: where you can make your specialty pharmacy perform better.
- 22:46Speaker 5: And so it's really a wonderful tool to use.
- 22:49Speaker 3: This was an important part of our coverage of the
- 22:51Speaker 3: NASP twenty twenty four, and Julianna, we really appreciate you
- 22:55Speaker 3: bringing this to light.
- 22:56Speaker 5: Thank you, thank you, thank you for having me The
- 23:02Speaker 5: NESP twenty twenty four here in Nashville. I'm with May Tang.
- 23:06Speaker 5: She is with Two Trees Consulting. May thanks for being
- 23:10Speaker 5: part of the show.
- 23:12Speaker 12: Thank you so much for having me.
- 23:14Speaker 3: All Right, So, using your associations and we go to
- 23:19Speaker 3: oh I think I go to eight to twelve conferences
- 23:21Speaker 3: per year. It's the associations that bring you in as
- 23:26Speaker 3: being part of something so that you feel as if
- 23:28Speaker 3: you're really making a difference. NASP is really good at that,
- 23:32Speaker 3: and you had that kind of experience. Talk to us
- 23:34Speaker 3: about working with people here at the NSP.
- 23:38Speaker 12: I'm a pharmacist for thirty years and I've been to
- 23:42Speaker 12: many conference conferences, and this is the conference that I
- 23:47Speaker 12: felt I belong.
- 23:49Speaker 5: I felt I had a voice.
- 23:52Speaker 12: I felt I have a platform to share my knowledge,
- 23:57Speaker 12: and I have wonderful connection and made wonderful connections with
- 24:02Speaker 12: other leaders in the industry. And I really just feel
- 24:06Speaker 12: so inspired by Sheila. She's so personal. She sends emails
- 24:13Speaker 12: every time I post something on LinkedIn. She take she
- 24:17Speaker 12: took personal interest. So I just feel like I'm very
- 24:22Speaker 12: welcomed here and seeing a lot of people in the
- 24:27Speaker 12: industry share the same passion, I'm just inspired.
- 24:32Speaker 3: That's really special to hear because it's those associations that
- 24:38Speaker 3: ultimately help patients receive better care because then the provider
- 24:42Speaker 3: that is you is feeling supportive, You're feeling that you
- 24:46Speaker 3: have a platform to stand on.
- 24:48Speaker 5: What about like continuing.
- 24:49Speaker 12: Education, wonderful topics that cover current challenges that pharmacies facing.
- 24:59Speaker 12: And we have just one offul speakers and I'm luckily
- 25:03Speaker 12: I'm unlucky participant in a couple of sessions that I
- 25:08Speaker 12: was able to share my experiences and I'm looking forward
- 25:12Speaker 12: to the next three days on one of four speakers
- 25:17Speaker 12: talking about what we're facing, pipeline legislation, operations, efficiency and
- 25:23Speaker 12: most importantly, patient care. How to deliver the best quality care.
- 25:29Speaker 12: And that's where the passion comes in. That's where we
- 25:33Speaker 12: build together because at the end of the day is
- 25:36Speaker 12: what we can do.
- 25:37Speaker 6: To have that patient in need.
- 25:40Speaker 5: That was awesome. Thank you so much, Maye for being
- 25:43Speaker 5: part of the show.
- 25:44Speaker 12: Thank you so much for having me.
- 25:49Speaker 9: Here.
- 25:49Speaker 3: We are an ASP twenty twenty four. Michael Meander, Please
- 25:55Speaker 3: tell us more about our tour solutions.
- 25:57Speaker 6: And what you guys do.
- 25:58Speaker 13: Todd, thanks for asking for well, it's an absolute pleasure
- 26:01Speaker 13: to be here and to meet you, and we're really
- 26:05Speaker 13: enjoying our time, so thank you so much for this
- 26:07Speaker 13: particular time. All to Our Solutions is a temperature sensitive
- 26:11Speaker 13: packaging company.
- 26:13Speaker 9: We're a manufacturer and so.
- 26:19Speaker 13: Big picture, twenty three facilities across the United States making
- 26:25Speaker 13: the cold chain temperature sensitive packaging. It's molded coolers for
- 26:29Speaker 13: the most part, serving into this our target market here
- 26:34Speaker 13: specialty pharmacy, and we sell direct to these pharmacies and
- 26:40Speaker 13: then some of the larger pharmacy benefit managers.
- 26:42Speaker 9: So this is right in our Bailly wick of where
- 26:46Speaker 9: we need to be here for sure.
- 26:49Speaker 3: Why is it important to come together at the National
- 26:52Speaker 3: Association of Specialty Pharmacies Annual. What happens here to fuse
- 26:57Speaker 3: multiple people and ideas and partners to get well.
- 27:01Speaker 13: It starts and ends with the patient, right, and so
- 27:06Speaker 13: there's some really unique medicines here that of course need
- 27:10Speaker 13: to be held between two and eight degrees celsius.
- 27:14Speaker 4: And so.
- 27:16Speaker 13: When you talk about that temperature sensitivity, it's really important
- 27:19Speaker 13: that everyone is on the same page because if the
- 27:22Speaker 13: patient doesn't receive the product at maximum efficacy.
- 27:27Speaker 6: It's not going to help solve their problems.
- 27:29Speaker 13: And so when everyone here is patient focused, then you
- 27:32Speaker 13: can share those ideas and that wisdom and that passion
- 27:35Speaker 13: and knowledge.
- 27:37Speaker 9: To me, that's really exciting.
- 27:38Speaker 6: So we're blessed to be a part of it, for sure.
- 27:41Speaker 3: When I think of the chillers that are probably inside
- 27:44Speaker 3: a specialty pharmacy, they take the medication out, they put
- 27:49Speaker 3: it into your packaging, they place it into some of
- 27:52Speaker 3: their logistics solutions or delivery vans or cars. How long
- 27:59Speaker 3: on average are we making sure that that medication is
- 28:04Speaker 3: chilled under your direction and your technology.
- 28:08Speaker 13: So it depends on where the patient lives really so,
- 28:12Speaker 13: and where the pharmacy is located, of course, and so
- 28:15Speaker 13: that duration is typically twenty four, forty eight and seventy
- 28:20Speaker 13: two hours. So it just depends on how long it
- 28:23Speaker 13: takes to get that medicine from from the dispenser to
- 28:27Speaker 13: the patient.
- 28:28Speaker 3: All Right, The packaging in and of itself and keeping
- 28:33Speaker 3: the temperature at a specific level is within that timeframe
- 28:37Speaker 3: it being held at a specific temperature.
- 28:40Speaker 13: It is, yeah, and so it's between two and eight
- 28:43Speaker 13: degrees celsius for the most part, which is what most.
- 28:45Speaker 9: Of these drugs are held.
- 28:47Speaker 13: And so you have to have the right amount of
- 28:50Speaker 13: refrigerant inside the right size carton to be held again
- 28:54Speaker 13: twenty four thirty six eight seventy two hours. Yeah, so
- 28:59Speaker 13: that's critical for sure. So a lot of science goes
- 29:02Speaker 13: that goes into that. For sure, you got densities of
- 29:05Speaker 13: the cooler wall thickness, how the lid adheres to the
- 29:08Speaker 13: to the box, what size carton you need over the box,
- 29:12Speaker 13: So certainly some engineering involved.
- 29:14Speaker 3: There, especially pharmacy. That's listening right now. How what's the
- 29:17Speaker 3: best place to go to get a hold of you?
- 29:20Speaker 13: Our website www dot All Tour Solutions A L T
- 29:26Speaker 13: O R S O l U t I O n
- 29:29Speaker 13: S dot com. Yeah, where there you can you can
- 29:32Speaker 13: check out our our products and services are on our site.
- 29:37Speaker 13: I'll tease the fact that we're rebranding and if you
- 29:41Speaker 13: go to our website today, it'll look a heck of
- 29:43Speaker 13: a lot different. Uh, come come January. So either way,
- 29:47Speaker 13: check us out now and then in the future. Yeah,
- 29:50Speaker 13: there's there's a lot to come with All Tour where
- 29:53Speaker 13: we've I've got a lot of exciting stuff happening, which
- 29:55Speaker 13: is why we're here for the first time this week,
- 29:57Speaker 13: and this this won't be our last n A S.
- 30:00Speaker 5: I can promise you that it's great, We'll see you
- 30:02Speaker 5: in Denver.
- 30:04Speaker 13: Thank you so much again, Todd, my pleasure.
- 30:06Speaker 9: Thanks.
- 30:12Speaker 3: Welcome to the Pharmacy Podcast Network's coverage of the NASP
- 30:16Speaker 3: twenty twenty four. Mike bauld Ziki, it's so good to
- 30:20Speaker 3: see you here at the NASP twenty twenty four.
- 30:22Speaker 9: Thanks, it's great to be here again.
- 30:25Speaker 14: Amazing show that the National Association, especially Pharmacy Sheila Kirk
- 30:31Speaker 14: and that team has really put together here down at
- 30:33Speaker 14: twenty twenty four expo in Nashville.
- 30:36Speaker 9: It's amazing. One.
- 30:37Speaker 14: I think one of the things I've really seen transition
- 30:41Speaker 14: into the specially pharmacy space is technology, and that's really
- 30:44Speaker 14: nothing new, but it's really showcasing the various you know,
- 30:48Speaker 14: I call it the labyrinth maze, that these technology companies
- 30:52Speaker 14: are really coming into this space pretty heavily in a
- 30:55Speaker 14: very different way, in a different fashion of what that
- 30:57Speaker 14: means for specially pharmacy.
- 30:59Speaker 3: So our physicians out there, the quarterbacks of healthcare pitching
- 31:04Speaker 3: the treatments to our specialty pharmacies little nervous sometimes because
- 31:09Speaker 3: they're like, is my patient going to get the care
- 31:12Speaker 3: that they need in order to really track and really
- 31:14Speaker 3: take care of this chronic disease state. You're sharing something
- 31:18Speaker 3: really novel and special that you've seen happening at the
- 31:23Speaker 3: physician's space where specially pharmacy is becoming a lot closer
- 31:27Speaker 3: parallel in being fused with that environment.
- 31:31Speaker 5: Talk to us about that.
- 31:32Speaker 9: Yeah, they are.
- 31:32Speaker 14: I mean, what's happening with I call them director provider
- 31:35Speaker 14: engagement platforms technologies.
- 31:37Speaker 9: And what does that mean for specially pharmacy?
- 31:40Speaker 14: Is these providers like what we're seeing in specially pharmacy
- 31:43Speaker 14: is the robust pipeline really explode into the especially pharmacy,
- 31:47Speaker 14: especially light products, but particularly rare disease biologics, etc. So
- 31:52Speaker 14: these physicians are more and more hammered with the labor
- 31:56Speaker 14: intensive lift of not only priuthorization but coordination of a
- 31:59Speaker 14: care making sure that they have access to these medications.
- 32:02Speaker 14: And what does access mean, especially even when you have
- 32:05Speaker 14: financial components that are constraining higher premiums in the insurance
- 32:09Speaker 14: benefits versus.
- 32:10Speaker 9: What do we do to manage these patients?
- 32:12Speaker 14: Because again, some of them are so very new not
- 32:14Speaker 14: only to providers but to the especially pharmacy space of
- 32:17Speaker 14: patient journey mapping that we have always talked about. So
- 32:21Speaker 14: I think what's happening is now is these providers are
- 32:25Speaker 14: really engaging and saying what do I do? And there's
- 32:28Speaker 14: a large number of new companies coming out in this
- 32:30Speaker 14: technology I call director provider provider engagement. That's saying, hey,
- 32:35Speaker 14: we have a platform, we are embedded into your EMAR
- 32:38Speaker 14: and we're doing some very unique things to now only
- 32:41Speaker 14: lift that labor, but ensuring we're streamlining the product, the
- 32:44Speaker 14: product access point of those medications. Besides ensuring that we're
- 32:48Speaker 14: getting it to the right pharmacy with the right financial component.
- 32:51Speaker 3: Within the right network which your organization are you focused
- 32:56Speaker 3: on now?
- 32:56Speaker 5: That's actually driving some of these solutions.
- 32:59Speaker 14: Now distorted a new role with the chief revenue officer
- 33:01Speaker 14: with Lyceum Health. We are a group of companies with
- 33:05Speaker 14: fill Point Health and we're really driving within dermatology and
- 33:09Speaker 14: getting into other therapeutical areas in twenty twenty five. But
- 33:13Speaker 14: you know, we're right in the hand of that director
- 33:16Speaker 14: provider engagement and we're working with a large number of
- 33:19Speaker 14: especially pharmacies, forming very unique networks around dermatology. Besides working
- 33:24Speaker 14: with Farman saying what does it matter in regards to
- 33:27Speaker 14: you and what do you need to see for patient
- 33:29Speaker 14: abandonment rate?
- 33:30Speaker 9: What does that mean the provider and how does especially.
- 33:32Speaker 14: Pharmacy insert themselves ensure that patients get access but also
- 33:36Speaker 14: that coordinated care is a streamlined process of not only
- 33:41Speaker 14: product access, but information to that patient and provider.
- 33:45Speaker 3: All right, how do you see the specialty pharmacies in
- 33:50Speaker 3: this network? How do you see them leveraging artificial intelligence
- 33:55Speaker 3: for better communication with the patient so that we're not
- 33:58Speaker 3: dropping the ball, especially in driving adherents.
- 34:01Speaker 14: Yeah, I mean AI is definitely stepping in, it's not
- 34:04Speaker 14: going away. And one of the things I think AI
- 34:06Speaker 14: is really going to be a very attractive component in
- 34:09Speaker 14: this technology era that we're stepping into is streamlining the.
- 34:12Speaker 9: Prior authorization process.
- 34:13Speaker 14: I mean there's a lot going on within those technology components,
- 34:18Speaker 14: and AI is how do we mesh up even geographical
- 34:21Speaker 14: preference versus the patient preference, medications medical necessit called medical
- 34:28Speaker 14: necessity with payer policies. So really, again, these are always
- 34:31Speaker 14: a step by step process when you're doing a PA,
- 34:34Speaker 14: even manly. So how does AI step in with that
- 34:37Speaker 14: patient profile, getting into the EMR and grabbing all the
- 34:40Speaker 14: information that's there that we really had never had access
- 34:43Speaker 14: to you and ensuring that we're really profiling these pro authorizations,
- 34:48Speaker 14: step edits and all the things that go into a
- 34:50Speaker 14: payer policy. They're ensure that we're providing the right information
- 34:53Speaker 14: at the right time to streamline and expedite that process
- 34:56Speaker 14: from them.
- 34:57Speaker 3: Mike, this is so good to finally catch up with you.
- 35:00Speaker 3: It's always here at NASP excited about what you're doing.
- 35:05Speaker 3: We're going to be on the lookout. What's you on LinkedIn?
- 35:07Speaker 3: Got to have you back and tell some stories with
- 35:09Speaker 3: some of these providers and partnerships that you've built, and
- 35:14Speaker 3: just thank you so much for what you do and
- 35:16Speaker 3: your commitment to ANASP as well.
- 35:18Speaker 14: Now Todd, as always, this is always a show that
- 35:21Speaker 14: I always look forward to and it's always growing.
- 35:23Speaker 9: But even your.
- 35:24Speaker 14: Presence within the Pharmacy podcast Network and what you're doing
- 35:27Speaker 14: out there to educate making sure that not at least
- 35:29Speaker 14: specially pharmacy is representing in a way but also NAS.
- 35:32Speaker 5: Absolutely thanks Mike, take care.
- 35:38Speaker 3: I always say technology and how it plays a role
- 35:42Speaker 3: not only in pharmacy, but more specifically our specialty pharmacy division.
- 35:47Speaker 3: We're here in Nashville, I'm here with Nick Reeze with
- 35:51Speaker 3: Key Centrics.
- 35:53Speaker 5: You have been part of our show.
- 35:56Speaker 3: Now I think this is your second or third year snick,
- 35:58Speaker 3: so I appreciate this.
- 36:00Speaker 6: It's great to be back. Have you been good?
- 36:02Speaker 9: Good?
- 36:03Speaker 6: This year's been crazy. You know, it's an election year,
- 36:06Speaker 6: so everything is.
- 36:08Speaker 3: Always crazy, you know, a little bit crazier during the
- 36:10Speaker 3: election year.
- 36:11Speaker 6: But it's been fun, a lot of fun.
- 36:13Speaker 15: This year's nas holy how it is it's blown up. Yeah,
- 36:18Speaker 15: we've been extremely busy. I think positioning of our booth.
- 36:22Speaker 15: You know, it's like the attack zone as as everybody
- 36:25Speaker 15: comes in.
- 36:27Speaker 6: But even after all the shirts are gone, we're still
- 36:30Speaker 6: really busy, which is good.
- 36:31Speaker 5: It is good.
- 36:33Speaker 15: We've been hearing a lot of people come up and say,
- 36:35Speaker 15: you know, we've been hearing a lot of good things
- 36:36Speaker 15: about you guys. We want to learn more, which I
- 36:39Speaker 15: feel like a lot of the sweat equity is coming forward.
- 36:41Speaker 6: You know that's a big thing.
- 36:43Speaker 3: Yeah, new headquarters in whichitah, congratulations, looks amazing. I don't
- 36:49Speaker 3: think the listeners. Some listeners understand this, others don't. So
- 36:53Speaker 3: if you're listening with the show, you're driving your car,
- 36:55Speaker 3: whatever you're doing right now. Key Centris has some very
- 36:58Speaker 3: very special routes in specialty pharmacy. I remember the beginnings
- 37:04Speaker 3: the literal beginnings of the workflow that was transferring our
- 37:08Speaker 3: pharmacies from a community environment to the specialty environment, and
- 37:13Speaker 3: how things were being organized and how you were creating
- 37:16Speaker 3: workflows within pharmacy software. The reason that was so novel
- 37:21Speaker 3: ten years ago is because everybody's thought of workflow and
- 37:25Speaker 3: specialty had to come from a different provider as a
- 37:29Speaker 3: bolt on or some kind of API that you were
- 37:32Speaker 3: building out of your community pharmacy system. Key Centrics took
- 37:36Speaker 3: it upon themselves to slow some things down, start being
- 37:39Speaker 3: very methodical and really mapped out what the future of
- 37:43Speaker 3: pharmacy technology would look like. And here we are today.
- 37:46Speaker 3: We're your full power. So talk to us about what's
- 37:49Speaker 3: happening at key Centrics. Now, why is there so much
- 37:52Speaker 3: attention on your organization. I know the answer to this,
- 37:55Speaker 3: but I don't think our listeners do. But what's happening
- 37:58Speaker 3: in your space where you're attracting specialty pharmacy.
- 38:02Speaker 15: Well, let's take that snap back real quick. So when
- 38:07Speaker 15: you're talking about a lot of people don't realize that
- 38:11Speaker 15: workflows can happen within a pharmacy management solution, is still
- 38:15Speaker 15: a lot of what's coming to our plate today.
- 38:18Speaker 6: We're talking to a lot of people where they're doing.
- 38:21Speaker 15: Things in like two or three different platforms, so they
- 38:23Speaker 15: don't realize that, like, this is something that can do everything.
- 38:27Speaker 15: We can manage that workflow, and we can configure that
- 38:29Speaker 15: workflow to mimic your I always say it's like a fingerprint.
- 38:33Speaker 15: Even though everybody kind of has a standard operating procedure,
- 38:36Speaker 15: there's a fingerprint that makes you special. And the fact
- 38:39Speaker 15: that we not only have that workflow that can do that,
- 38:42Speaker 15: we can manage it and change that workflow to really
- 38:45Speaker 15: adapt to the go to market strategy, out to whatever specialty,
- 38:49Speaker 15: pharmacy or inclusion that is in play today. And so
- 38:53Speaker 15: I think there's a little bit of nomenclature sometimes when
- 38:57Speaker 15: we speak to new clients that they will automatically come
- 39:01Speaker 15: into a mindset of we need to do all the
- 39:05Speaker 15: integration and we just want to use adjudication out of
- 39:08Speaker 15: you and maybe a PV and then that's it. And
- 39:10Speaker 15: then we have a demo and they're like, oh, this
- 39:15Speaker 15: is okay, Well hold on. So you have integrations with
- 39:19Speaker 15: shipping providers, you have integration, but you open APIs where
- 39:22Speaker 15: we can pull things back and forth. When you're talking
- 39:24Speaker 15: about hubs being able to truncate workflow, grab information, bring
- 39:29Speaker 15: it right back, and then continue workflow facts out.
- 39:32Speaker 6: We have all these different APIs that we can manage
- 39:35Speaker 6: that sort of scenario for you. Or if it's just.
- 39:37Speaker 15: Regular specialty, a lot of times they've built a proprietary
- 39:40Speaker 15: solution that is like just they're growing and it's not working,
- 39:44Speaker 15: but they still want to use certain features and it's
- 39:47Speaker 15: becoming a real a play of hey, do we keep
- 39:51Speaker 15: what we have today and then integrate or do we
- 39:54Speaker 15: just use you as a record of truth and nine
- 39:55Speaker 15: times out of tennis a record of truth. But I
- 39:58Speaker 15: think that's the other part that we really do well
- 40:00Speaker 15: with is understanding what is the go to market strategy
- 40:06Speaker 15: today and what are they trying to achieve later on,
- 40:11Speaker 15: And we have a roadmap that we can talk about
- 40:13Speaker 15: with them of this is what we're doing, but we
- 40:16Speaker 15: also offer it's an agile roadmap where we offer development
- 40:20Speaker 15: to really build to help our clients succeed in the
- 40:24Speaker 15: direction that they're going. Whether it's today with all the
- 40:27Speaker 15: different constraints that are going on, whether you know it's
- 40:31Speaker 15: the same old thing of you know, medication, high cost,
- 40:35Speaker 15: low reimbursement, high cost of the patient, How do we manage.
- 40:39Speaker 6: Those three forty D programs all that sort of stuff.
- 40:42Speaker 15: And then it's the you know, you have pharmacy management
- 40:45Speaker 15: systems that are either going out of business or changing
- 40:47Speaker 15: their structure, and that's giving them time to rethink. From this,
- 40:50Speaker 15: it is time to rethink.
- 40:52Speaker 6: And where it comes down to play is like when they're.
- 40:56Speaker 15: Trying to make a decision of who to go to
- 40:59Speaker 15: and the reason why. A lot of times there's a
- 41:02Speaker 15: lot of miss in that evaluation process.
- 41:04Speaker 6: And I think.
- 41:07Speaker 15: When we talk to clients or perspective clients and even
- 41:10Speaker 15: our own clients, I think we do a really good
- 41:12Speaker 15: job of really sitting down and understanding are you part
- 41:16Speaker 15: of a health system?
- 41:17Speaker 6: What does that look like?
- 41:19Speaker 15: Do you have a central film, you have a courier system?
- 41:22Speaker 15: Do you have a mail order aspect to you? Do
- 41:24Speaker 15: you want to have an as specialty drugs? What type
- 41:26Speaker 15: of confusion are you doing? Is it an ambulatory is
- 41:29Speaker 15: at home? How does that business model understand it completely?
- 41:33Speaker 6: And that way? For one, are we a good bid too?
- 41:36Speaker 6: How are we going to make.
- 41:37Speaker 15: Sure that we have the best half of success today
- 41:40Speaker 15: and in the future. And I think that's that's a
- 41:42Speaker 15: big difference from how things are going and with what
- 41:46Speaker 15: we hear with.
- 41:46Speaker 6: The evaluation process.
- 41:48Speaker 15: And unfortunately, when you have somebody that's switched and then
- 41:52Speaker 15: now is needing to switch again, then you look at
- 41:55Speaker 15: attrition of your own staff and sometimes it's like, you know,
- 41:58Speaker 15: you see a family member because they've been with you
- 42:01Speaker 15: from the beginning.
- 42:02Speaker 6: But it's just too stressful.
- 42:04Speaker 15: And that's what we're trying to really get the signs
- 42:07Speaker 15: down of understanding how to make sure that that's not
- 42:10Speaker 15: an issue later on, and how do we develop a
- 42:12Speaker 15: solution that can make sure that we need the needs
- 42:14Speaker 15: and we have the versatility to.
- 42:16Speaker 3: Be able to do that. Act. Tell us about the
- 42:19Speaker 3: portfolio though, because back in the day when I was
- 42:22Speaker 3: doing consulting for Key Centrics, you were heavy in community pharmacy,
- 42:27Speaker 3: independent community, and we evolved into specialty. Now you're a
- 42:32Speaker 3: champion of specialty, but there's other things like send key
- 42:35Speaker 3: and things that are kind of amplifying the system in
- 42:38Speaker 3: it itself.
- 42:39Speaker 5: Talked about the portfolio.
- 42:41Speaker 15: Yeah, so portfolio, let's go with portfolio clients. So, like
- 42:46Speaker 15: you said before, it was like rx key, a lot
- 42:48Speaker 15: of retail moved over to specialty pharmacy, doing really good
- 42:52Speaker 15: in specialty pharmacy, independent pharmacy.
- 42:56Speaker 6: Chain as well.
- 42:57Speaker 15: But what we've developed is not only the base newly
- 43:02Speaker 15: pharmacy management solution. We also have like you said, send
- 43:04Speaker 15: key LISS is that patient prescriber communication. But what that
- 43:09Speaker 15: helps you do is automate some processes through communication to
- 43:13Speaker 15: those providers and patients.
- 43:16Speaker 6: Of what's happening with that prescription. So something that we
- 43:19Speaker 6: just released is bidirection SMS.
- 43:22Speaker 15: Now, the change of bidirectional SMS versus what we had
- 43:26Speaker 15: before is in workflow, you can trigger responses to say
- 43:30Speaker 15: thank you so much Todd for justin a pharmacy AYZ
- 43:34Speaker 15: for your prescription, stay tuned for more, here's your tracking
- 43:37Speaker 15: number for mail order, whatever it may be, things to
- 43:42Speaker 15: go out to, specific demographics.
- 43:44Speaker 6: All sorts of different business rules that you can do
- 43:45Speaker 6: with all that.
- 43:46Speaker 15: Now, the bi directional SMS allows you to actually have
- 43:49Speaker 15: a conversation, so with your provider or your patient what's
- 43:53Speaker 15: happening with a prescription. If there's additional let's say you
- 43:56Speaker 15: have plannical activities that you need additional information.
- 43:58Speaker 6: Reach out to one for this schedule, this, whatever it
- 44:01Speaker 6: may be.
- 44:01Speaker 15: There's a you could just text them and that's a
- 44:05Speaker 15: full file of text, so you can go back on
- 44:07Speaker 15: dates to look at exactly what happened, who talked to
- 44:09Speaker 15: who at when, what was said? Transfer of information so
- 44:12Speaker 15: documents can be sent through that as well. So it's
- 44:15Speaker 15: a huge functionality that we released this year that I
- 44:18Speaker 15: think is really taking traction in our current clients, and
- 44:22Speaker 15: when we talk about with other people, it's like a, oh, oh,
- 44:25Speaker 15: that's kind of nice, you know that I could see
- 44:27Speaker 15: that happen in so many different applications of their workflow today.
- 44:33Speaker 15: I think the other part as far as the portfolio
- 44:36Speaker 15: is adding infusion.
- 44:38Speaker 6: And that's I think a huge.
- 44:41Speaker 15: Aspect because as pharmacy specialty pharmacy grows, they're always trying
- 44:46Speaker 15: to expand either a footprint via mail order or a
- 44:50Speaker 15: new service or even infusion that's ambulatory and looking to
- 44:54Speaker 15: go to home infusion, those sort of scenarios. Being able
- 44:59Speaker 15: to capture and manage infusion aspects like TPN, factor management IVG,
- 45:06Speaker 15: that's something that we really focused on this year extremely
- 45:10Speaker 15: hard and sat with consultants, customers, perspective, customers. I mean,
- 45:14Speaker 15: we've really got a large swath to understand exactly what
- 45:18Speaker 15: was needed.
- 45:18Speaker 6: And I was just talking about this just recently.
- 45:22Speaker 15: The factor management, like the fact that we can pull
- 45:25Speaker 15: a lot of what's done on Excel, the range calculations,
- 45:28Speaker 15: which are extremely complicated, and pull that into our system
- 45:31Speaker 15: and manage it through there so you're not having to
- 45:34Speaker 15: go to anything else. You have one source of truth
- 45:37Speaker 15: and you can just manage that within the solution. Is
- 45:40Speaker 15: a huge aspect. So there's the new leaf, there's the
- 45:46Speaker 15: sen Key functionality that we talked about, and then also
- 45:49Speaker 15: when you're talking to like healthcare systems that have a
- 45:51Speaker 15: little bit of retail and specialty, we have the flex tracks,
- 45:56Speaker 15: so it's like the point of sales, you're able to
- 45:57Speaker 15: scan items and take signature.
- 46:00Speaker 6: So good right there too.
- 46:01Speaker 15: So there's a full encompassing that's been a lot of
- 46:04Speaker 15: change from the r X key days to the course evolution,
- 46:09Speaker 15: newity to where we are there.
- 46:10Speaker 3: It's great Nick, thanks for being part of the NASP podcast.
- 46:14Speaker 3: You always bring new insights to us for technology. We
- 46:18Speaker 3: hope to see you in Denver for twenty twenty.
- 46:20Speaker 6: Five A Denver's gonna be nice, all right, Thank you
- 46:23Speaker 6: there much.
- 46:28Speaker 3: One of my favorite aspects of coming to the NASP
- 46:31Speaker 3: and focused on specialty pharmacy is meeting new champions in
- 46:35Speaker 3: the space, and there's so many components of the ecosystem
- 46:38Speaker 3: of what we do. I like to say together our
- 46:41Speaker 3: ex Alison Urant from Clearway Health, Senior vice president of
- 46:47Speaker 3: Client Development and Marketing, Welcome to the.
- 46:49Speaker 11: Show, Thanks Todd, thanks for having me.
- 46:51Speaker 5: Very welcome.
- 46:51Speaker 3: All right, right out of the gate, we want to
- 46:53Speaker 3: know what are you doing in specialty pharmacy?
- 46:56Speaker 5: What's Clearway Health.
- 46:58Speaker 11: Clearway Health partners with hospital and health systems to build
- 47:01Speaker 11: and transform specialty pharmacy programs. So we come alongside them
- 47:05Speaker 11: wherever they are in their specialty pharmacy journey. Some of
- 47:08Speaker 11: our clients have pharmacies today and they may not offer
- 47:12Speaker 11: specialty pharmacy services. Some don't have pharmacies at all, and
- 47:16Speaker 11: some have really robust and sophisticated specialty pharmacy programs where
- 47:20Speaker 11: they have been able to serve patients through their own
- 47:22Speaker 11: specialty pharmacy services and have reached a peak or a plateau,
- 47:26Speaker 11: and they're looking for ways to navigate obstacles, to continue
- 47:28Speaker 11: to grow and to build and to transform their programs,
- 47:31Speaker 11: and so we partner with them providing services from the
- 47:34Speaker 11: very beginning. We embed staff inside of their clinical spaces,
- 47:38Speaker 11: we help them open pharmacies, we help them staff them,
- 47:41Speaker 11: and even manage some of the tough parts of the
- 47:43Speaker 11: landscape like accreditation, pay your Access PBM, and manufacture strategies
- 47:48Speaker 11: and every step along the way.
- 47:49Speaker 3: That's terrific because there are a lot of organizations, a
- 47:52Speaker 3: lot of health systems on hospitals that are out there
- 47:54Speaker 3: that are scratching their heads saying where are we going
- 47:57Speaker 3: to come up with a specialty pharmacy solution, And it's
- 48:00Speaker 3: daunting to think of building that from the ground up.
- 48:03Speaker 5: So it sounds like you're giving.
- 48:04Speaker 3: People a quality and clear pathway in getting into specialty pharmacy.
- 48:11Speaker 5: That's right.
- 48:12Speaker 11: I think the quality part is really important because we
- 48:15Speaker 11: talk so much about the benefit of specialty pharmacy, and
- 48:18Speaker 11: historically pharmacy has been such largely an inpatient service line,
- 48:23Speaker 11: and so it's only been in recent years that hospitals
- 48:26Speaker 11: and health systems have looked into the outpatient space and
- 48:29Speaker 11: providing either retail or specialty pharmacy services. And it's hard
- 48:33Speaker 11: because it's not something that is native and familiar for
- 48:36Speaker 11: a lot of hospitals and health systems. And the challenge
- 48:39Speaker 11: is people look at specialty pharmacy as they should as
- 48:42Speaker 11: a way to provide an expanded service line to their patients.
- 48:46Speaker 11: But it's often hard to navigate the complexities required to
- 48:49Speaker 11: do it, and it's often seen as this incredible transformative
- 48:53Speaker 11: financial opportunity. But you mentioned quality, and I think that
- 48:57Speaker 11: is more important, certainly as important and then all of
- 49:00Speaker 11: the other components, because building a sustainable and scalable asset
- 49:04Speaker 11: for an organization has to be patient centered to deliver
- 49:07Speaker 11: the clinical quality alongside the operational and financial improvements that
- 49:11Speaker 11: this kind of service can bring for our listeners.
- 49:14Speaker 3: I want you to go to clearwayhealth dot com. I
- 49:18Speaker 3: also want to give a shout out to Nicole Foucher,
- 49:20Speaker 3: your president, who wrote a really good piece on the
- 49:24Speaker 3: four important practices amid GLP one medication reshaping healthcare. What
- 49:29Speaker 3: an interesting article that is because of lack of that
- 49:34Speaker 3: medication not owing the longevity you know, starting out on it,
- 49:39Speaker 3: so kind of elaborate on Nicole's thoughts.
- 49:42Speaker 11: Sure GLP once have been a wild ride for everyone
- 49:46Speaker 11: over the last few years, and certainly for hospitals and
- 49:49Speaker 11: health systems who are facing this decision point of a
- 49:51Speaker 11: few things, one was access. You talked about the shortages
- 49:54Speaker 11: and people faced a lot of challenges that created opportunity
- 49:58Speaker 11: for other more national players to come in and say, hey,
- 50:02Speaker 11: we want to provide these kind of remote, fee for
- 50:05Speaker 11: service kind of enrollments or subscriptions for people who are
- 50:08Speaker 11: looking for these drugs for weight loss. And then it
- 50:11Speaker 11: really created challenges for hospitals and health systems where one
- 50:15Speaker 11: they had to figure out how to get that medication
- 50:17Speaker 11: for the diabetic patients who have been on it for
- 50:19Speaker 11: a long time and who desperately need it. Two, how
- 50:21Speaker 11: to provide the same service to patients who are looking
- 50:24Speaker 11: to GLP ones for weight loss, and then three how
- 50:28Speaker 11: they really protect and defend their market share from these
- 50:31Speaker 11: larger players who are truly building these subscription kind of
- 50:34Speaker 11: buy ins for patients that create what is seemingly a
- 50:37Speaker 11: more easy access to these meds. And so Nicole talked
- 50:42Speaker 11: a lot about the ways that the market has changed
- 50:45Speaker 11: and how hospitals and health systems can build strategies around
- 50:48Speaker 11: these programs to be able to deliver the service to
- 50:50Speaker 11: both patients who are requiring these medications for diabetic patient
- 50:54Speaker 11: treatments as well as weight loss treatments. We've had a
- 50:58Speaker 11: lot of success partnering with our clients science where we
- 51:01Speaker 11: are building GLP one programs and we are building clinics
- 51:04Speaker 11: with specialty pharmacy focused with clinical pharmacist embedded to help
- 51:09Speaker 11: navigate these patients. Because there's a tremendous volume that no
- 51:13Speaker 11: one expected, andtoprenologists aren't staffed and their clinics aren't staffed
- 51:17Speaker 11: to support the increased volume of patients. So we are
- 51:20Speaker 11: building these clinics and using clinical pharmacists as an extension
- 51:24Speaker 11: of that care team to be able to serve patients
- 51:27Speaker 11: and to help meet the needs of the hospital and
- 51:28Speaker 11: health system and help them to protect and defend the
- 51:31Speaker 11: market while serving the patients that are natively being cared
- 51:33Speaker 11: for in their system.
- 51:35Speaker 3: Allison, thanks so much for being part of the coverage
- 51:37Speaker 3: here at the NSP twenty twenty four. We're going to
- 51:40Speaker 3: want to work with clear Way Health and twenty twenty five,
- 51:43Speaker 3: so I'll be reaching out to you.
- 51:44Speaker 1: Thanks, we look forward to it.
- 51:49Speaker 3: Doctor Amanda A is back in asph twenty twenty four.
- 51:54Speaker 5: You're starting to make this a thing. This is a tradition.
- 51:58Speaker 5: Now you have to keep doing it. So how is
- 52:01Speaker 5: your year If it's fantastic?
- 52:04Speaker 3: Yeah, what's happening with VPL in the world of specialty pharmacy.
- 52:08Speaker 9: Yeah, we are.
- 52:09Speaker 16: Really cluing into how we add value to the customers
- 52:14Speaker 16: that really love us and just starting to ask why, right,
- 52:18Speaker 16: why do you love us? So that we can, you know,
- 52:22Speaker 16: talk about the different problems and gaps and pain points
- 52:27Speaker 16: that we can solve in the same way for customers
- 52:30Speaker 16: LIKESAP pharmacies that are similar.
- 52:32Speaker 3: There's lots of listeners out there listening right now to
- 52:35Speaker 3: the post show, So just in case they don't remember
- 52:38Speaker 3: you on twenty twenty three, talk to us about what
- 52:41Speaker 3: VPL does in.
- 52:43Speaker 5: The pharmacy specialty pharmacy space. Glad too.
- 52:46Speaker 16: So we are a software company and we make solutions
- 52:50Speaker 16: predominantly for the last mile of the therapy journey. So
- 52:54Speaker 16: think after prescriptions, dispense has been verified and we need
- 52:58Speaker 16: to get it to the side of care. Normally that's
- 53:00Speaker 16: a patient's home. Sometimes it can be.
- 53:01Speaker 7: A doctor's office or other other types of addresses.
- 53:05Speaker 5: So are you doing.
- 53:09Speaker 3: Delivery, local, national, both? Does it depend cold stories like
- 53:15Speaker 3: talk to us about the options.
- 53:16Speaker 16: That you do with yeah, yes, yes, and all of
- 53:19Speaker 16: and all of the above and everything in between.
- 53:22Speaker 9: Yeah.
- 53:22Speaker 16: So it's so it's really the beauty of our solution.
- 53:26Speaker 16: And you know, I was a pharmacist before. I guess
- 53:29Speaker 16: I still am in some ways. But the beauty of
- 53:32Speaker 16: it is that every pharmacy is a snowflake, is what
- 53:34Speaker 16: we like to say. So every you know, specialty pharmacy
- 53:38Speaker 16: has their different communities and patient populations and different types
- 53:41Speaker 16: of therapies that they're dispensing, and so their needs for
- 53:44Speaker 16: the distribution are going to be very different.
- 53:47Speaker 5: Their workflows are different.
- 53:49Speaker 16: Some of them are just starting out, some of them
- 53:51Speaker 16: are ready to just explode with growth. But the one
- 53:54Speaker 16: common thread there is that they need, you know, a configurable,
- 53:58Speaker 16: reliable solution that not only right, there's a technology aspect,
- 54:02Speaker 16: there's an expertise aspect as well, and so we can
- 54:06Speaker 16: check all those boxes and that's what we strive to
- 54:10Speaker 16: do even better every day.
- 54:12Speaker 5: Thanks So one of the.
- 54:14Speaker 3: One of the aspects of business, not just specialty, that VPL,
- 54:20Speaker 3: in my opinion, is helping with.
- 54:22Speaker 5: We've lost over eight thousand community.
- 54:26Speaker 3: Pharmacies just in the last twenty four months, and the
- 54:29Speaker 3: widening span of pharmacy deserts is not only prevalent, but
- 54:33Speaker 3: it's threatening public health. VPL steps in and it is
- 54:37Speaker 3: able to shrink those pharmacy deserts based on coordinated delivery.
- 54:44Speaker 3: Talk to us a little bit about pharmacy deserts and
- 54:46Speaker 3: vpl's plans for twenty twenty five.
- 54:48Speaker 16: Absolutely, yeah, so huge issues, something I'm very passionate about
- 54:53Speaker 16: as well. We use data, right, Data doesn't lie, and
- 54:57Speaker 16: so when we look when we have.
- 54:59Speaker 5: Just like hips, hips don't lie, data doesn't lie.
- 55:02Speaker 16: Right, that's right, Yeah, there's lots of them back there.
- 55:06Speaker 16: But yeah, so so so looking at those addresses, right,
- 55:10Speaker 16: we can we can do all kinds of analyzes and
- 55:13Speaker 16: you know, we have teams and different programs that can
- 55:16Speaker 16: do so and expertise of course on board, and we
- 55:19Speaker 16: can say, okay, how can we better serve this community.
- 55:21Speaker 16: We can go down to the zip code level, we
- 55:23Speaker 16: can look health system level, we can look statewide. Right,
- 55:26Speaker 16: there's different lenses that we can put on it. But ultimately,
- 55:30Speaker 16: when you're thinking about things in it through a data
- 55:34Speaker 16: backed lens, right, science, science back, we're making decisions that
- 55:38Speaker 16: are not based on what we think, but what we
- 55:41Speaker 16: know to be true, so that we can really pinpoint
- 55:43Speaker 16: those problems and sign find solutions that are going.
- 55:46Speaker 5: To actually work.
- 55:48Speaker 3: Doctor Amanda, thank you so much for once again participating
- 55:51Speaker 3: in the show.
- 55:52Speaker 5: How do we reach out to you? What's the best
- 55:54Speaker 5: place to get a hold of you? My pleasure.
- 55:57Speaker 16: Get vpl dot com is our website.
- 55:59Speaker 7: I'm LinkedIn Amanda L.
- 56:01Speaker 4: A W. E.
- 56:03Speaker 16: And those are probably the best ways.
- 56:05Speaker 5: Awesome v get v p l dot com excellent. We'll
- 56:10Speaker 5: talk to you next year.
- 56:11Speaker 6: Thank you so much.